全文获取类型
收费全文 | 7297篇 |
免费 | 692篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 103篇 |
儿科学 | 239篇 |
妇产科学 | 176篇 |
基础医学 | 982篇 |
口腔科学 | 138篇 |
临床医学 | 701篇 |
内科学 | 1418篇 |
皮肤病学 | 91篇 |
神经病学 | 771篇 |
特种医学 | 477篇 |
外科学 | 994篇 |
综合类 | 144篇 |
一般理论 | 5篇 |
预防医学 | 707篇 |
眼科学 | 40篇 |
药学 | 427篇 |
中国医学 | 1篇 |
肿瘤学 | 585篇 |
出版年
2021年 | 108篇 |
2019年 | 94篇 |
2018年 | 97篇 |
2017年 | 82篇 |
2016年 | 100篇 |
2015年 | 101篇 |
2014年 | 163篇 |
2013年 | 209篇 |
2012年 | 299篇 |
2011年 | 303篇 |
2010年 | 203篇 |
2009年 | 196篇 |
2008年 | 308篇 |
2007年 | 331篇 |
2006年 | 299篇 |
2005年 | 312篇 |
2004年 | 302篇 |
2003年 | 277篇 |
2002年 | 252篇 |
2001年 | 248篇 |
2000年 | 244篇 |
1999年 | 242篇 |
1998年 | 97篇 |
1997年 | 91篇 |
1996年 | 82篇 |
1995年 | 65篇 |
1994年 | 55篇 |
1992年 | 145篇 |
1991年 | 177篇 |
1990年 | 189篇 |
1989年 | 183篇 |
1988年 | 147篇 |
1987年 | 149篇 |
1986年 | 135篇 |
1985年 | 156篇 |
1984年 | 116篇 |
1983年 | 100篇 |
1982年 | 66篇 |
1981年 | 67篇 |
1980年 | 61篇 |
1979年 | 87篇 |
1978年 | 70篇 |
1977年 | 67篇 |
1976年 | 68篇 |
1975年 | 65篇 |
1974年 | 78篇 |
1973年 | 74篇 |
1972年 | 67篇 |
1971年 | 61篇 |
1969年 | 65篇 |
排序方式: 共有7999条查询结果,搜索用时 15 毫秒
101.
102.
Barth RF Soloway AH Goodman JH Gahbauer RA Gupta N Blue TE Yang W Tjarks W 《Neurosurgery》1999,44(3):433-50; discussion 450-1
Boron neutron capture therapy (BNCT) is based on the nuclear reaction that occurs when boron-10, a stable isotope, is irradiated with low-energy thermal neutrons to yield alpha particles and recoiling lithium-7 nuclei. For BNCT to be successful, a large number of 10B atoms must be localized on or preferably within neoplastic cells, and a sufficient number of thermal neutrons must be absorbed by the 10B atoms to sustain a lethal 10B (n, alpha) lithium-7 reaction. There is a growing interest in using BNCT in combination with surgery to treat patients with high-grade gliomas and possibly metastatic brain tumors. The present review covers the biological and radiobiological considerations on which BNCT is based, boron-containing low- and high-molecular weight delivery agents, neutron sources, clinical studies, and future areas of research. Two boron compounds currently are being used clinically, sodium borocaptate and boronophenylalanine, and a number of new delivery agents are under investigation, including boronated porphyrins, nucleosides, amino acids, polyamines, monoclonal and bispecific antibodies, liposomes, and epidermal growth factor. These are discussed, as is optimization of their delivery. Nuclear reactors currently are the only source of neutrons for BNCT, and the fission reaction within the core produces a mixture of lower energy thermal and epithermal neutrons, fast or high-energy neutrons, and gamma-rays. Although thermal neutron beams have been used clinically in Japan to treat patients with brain tumors and cutaneous melanomas, epithermal neutron beams now are being used in the United States and Europe because of their superior tissue-penetrating properties. Currently, there are clinical trials in progress in the United States, Europe, and Japan using a combination of debulking surgery and then BNCT to treat patients with glioblastomas. The American and European studies are Phase I trials using boronophenylalanine and sodium borocaptate, respectively, as capture agents, and the Japanese trial is a Phase II study. Boron compound and neutron dose escalation studies are planned, and these could lead to Phase II and possibly to randomized Phase III clinical trials that should provide data regarding therapeutic efficacy. 相似文献
103.
Goodman SB Song Y Chun L Regula D Aspenberg P 《The Journal of bone and joint surgery. British volume》1999,81(6):1069-1075
We implanted bone harvest chambers (BHCs) bilaterally in ten mature male New Zealand white rabbits. Polyethylene particles (0.3+/-0.1 microm in diameter, 6.4 x 10(12) particles/ml) were implanted for two, four or six weeks bilaterally in the BHCs, with subsequent removal of the ingrown tissue after each treatment. In addition to the particles, one side also received 1.5 microg of recombinant transforming growth factor beta1 (TGFbeta1). At two weeks, the bone area as a percentage of total area was less in chambers containing TGFbeta compared with those with particles alone (7.8+/-1.3% v 16.9+/-2.7% respectively; 95% confidence interval (CI) for difference -14.0 to -4.30; p = 0.002). At four weeks, the percentage area of bone was greater in chambers containing TGFbeta compared with those with particles alone (31.2+/-3.4% v 22.5+/-2.0% respectively; 95% CI for difference 1.0 to 16.4; p = 0.03). There were no statistical differences at six weeks, despite a higher mean value with TGFbeta treatment (38.2+/-3.9% v 28.8 +/-3.5%; 95% CI for difference -4.6 to 23.3; p = 0.16). The number of vitronectin-receptor-positive cells (osteoclast-like cells) was greater in the treatment group with TGFbeta compared with that with particles alone; most of these positive cells were located in the interstitium, rather than adjacent to bone. TGFbeta1 is a pleotropic growth factor which can modulate cellular events in the musculoskeletal system in a time- and concentration-dependent manner. Our data suggest that there is an early window at between two and six weeks, in which TGFbeta may favourably affect bone ingrowth in the BHC model. Exogenous growth factors such as TGFbeta may be a useful adjunct in obtaining osseointegration and bone ingrowth, especially in revisions when there is compromised bone stock and residual particulate debris. 相似文献
104.
Strabismus: accommodative component treated by LASIK. 总被引:2,自引:0,他引:2
D Goodman 《Survey of ophthalmology》1999,44(2):183-184
105.
Dislodgement of Intracoronary Thrombus During Angiography in a Patient with Unstable Angina Pectoris
A patient with unstable angina pectoris in whom thrombus release from intracoronary lesion was seen during angiography is described. The event resulted in improvement of vessel patency and resolution of ischemic symptoms. To our knowledge, only two similar cases have been reported in English literature since 1966. 相似文献
106.
Eighty four out of 2151 militancy trauma patients sustained severe maxillofacial injury from Jan 1990 to March 1993. The resuscitation, stabilisation and intensive care of these patients was based on management priorities of primary resuscitation, care of airway, management of haemodynamics, oxygenation and monitoring. Anaesthesia was administered in a situation when the airway was likely to be compromised and the patients were critically sick. Initial ventilation and oxygenation was the most difficult and could be achieved with satisfactory seal around the face mask by applying water-soaked guaze pieces around the mouth and nose to “fill-in” the defects. Tracheal intubation could be accomplished with intravenous sedation by an experienced anaesthesiologist. Dental occlusion and wiring necessiated the placement of nasotracheal tube for 48-72 hours after surgery.KEY WORDS: Trauma, Maxillofacial injury, Trauma anesthesia, Anaesthesia and critical care 相似文献
107.
108.
109.
Cowden syndrome and Lhermitte-Duclos disease. 总被引:7,自引:0,他引:7
BACKGROUND. Cowden syndrome (CS) is a rare but underdiagnosed autosomal dominant condition also known as "multiple hamartoma-neoplasia syndrome." Patients have multiple tricholemmomas (a type of benign skin appendage tumor) and oral papillomatosis and cutaneous keratoses. They often have goiter, gastrointestinal polyps, and hamartomatous soft tissue lesions. Breast cancer affects approximately one third of women with CS. Lhermitte-Duclos disease (LDD) is a peculiar proliferation of abnormal neuronal elements of the cerebellum that has features of a hamartoma and of a neoplasm. METHODS. The authors described two patients who have both CS and LDD. Also reviewed were 50 of approximately 62 previously described cases of LDD (identified through literature searches) in an effort to find patients with LDD who had other associated lesions. RESULTS. Only one other patient in whom both LDD and CS were recognized has been reported. In addition, a number of patients with LDD who had other neoplasms and/or thyroid lesions have been described. CONCLUSIONS. Given the rarity of these two entities, we believe that their association is not fortuitous. LDD fits into the concept of CS as a hamartoma-neoplasia syndrome. In addition, a number of patients with LDD who had other neoplasms or thyroid lesions have been reported, raising the possibility that CS and LDD are more closely linked than is generally appreciated. We suspect that there are more patients with LDD who have unrecognized CS. Patients with either of the two diseases should be examined and followed up for evidence of the other. 相似文献
110.
P Aspenberg S Goodman S Toksvig-Larsen L Ryd T Albrektsson 《Acta orthopaedica Scandinavica》1992,63(2):141-145
We studied the effects of micromotion on bone ingrowth into a 1-mm canal through a titanium chamber implanted in the proximal tibia of rabbits. The implant surface became "osseointegrated," but an interior core was movable, allowing the central portion of the canal to be moved in relation to the ends. Thus, the ingrowing bone in the canal had to pass an area of ad latus motion. When implanted in rabbit tibiae, the canal became filled with ingrown cancellous bone. Bone ingrowth was inhibited by 20 cycles of 0.5-mm movement applied during a 30-second period once daily. With this regimen, the canal was usually filled with vascularized fibrous tissue and significantly less bone. The micromotion chamber may enable detailed studies of the effects of different motion variables on ingrowth of bone. 相似文献